Case Study (Canada)
How can I protect market share and drive HCP advocacy when facing aggressive competition from a lower-quality product?
Facing increased competition from a deep-pocketed rival, a leading OTC healthcare brand needed a rapid, effective strategy to protect market share and reinforce its reputation for patient-centered care.
Inizio Engage delivered a targeted HCP engagement program – deploying both field and remote representatives – that generated immediate commercial impact and long-term advocacy.
The Challenge
A Challenger Threatens Category Stability and Patient Health
A new market entrant had launched an inferior product into a specific OTC segment, leveraging scale and aggressive marketing tactics to gain traction.
Although the competitor lacked clinical strength, its pricing strategy and operational efficiency posed a significant threat to established brands.
Our client sought to protect its position, safeguard consumer trust, and ensure pharmacists and GPs continued to recommend its product based on quality and outcomes.
Our Solution
Rapid Deployment of Field and Virtual Teams
Inizio Engage quickly mobilized two specialist teams to drive targeted engagement and counter the competitor’s strategy:
National Team: Four Virtual Territory Managers (VTMs) focused on engaging pharmacists – key stakeholders in OTC recommendations and purchasing behavior.
Provincial Team: A localized Field Team targeted general practitioners in a key market where brand preference influenced consumer decisions.
Execution Excellence
Aligning Clinical Evidence with HCP Priorities
Both teams were armed with insight-driven messaging designed to expose weaknesses in the competitor’s offer while reinforcing the brand’s superior clinical data and legacy of patient-first care.
This narrative was carefully aligned to the priorities of each audience – ensuring pharmacists and GPs received relevant, impactful content that addressed their specific concerns and supported confident recommendations.
The Inizio Engage Impact
Sales Growth and Recommendation Share
- +9% uplift in topline sales within just three months
- #1 position in recommendation share by Q3 2025.
- +4.6 percentage point gain in GP recommendation share.
- +1.8 percentage point gain among pharmacists.
These outcomes proved that with the right mix of strategy, speed, and execution, brands can defend market leadership and drive new growth – even in the face of aggressive disruption.
